Artificial intelligence of things for smarter healthcare: a survey of advancements, challenges, and opportunities

S Baker, W **ang - IEEE Communications Surveys & Tutorials, 2023 - ieeexplore.ieee.org
Healthcare systems are under increasing strain due to a myriad of factors, from a steadily
ageing global population to the current COVID-19 pandemic. In a world where we have …

Anxiety, depression, trauma-related, and sleep disorders among healthcare workers during the COVID-19 pandemic: A systematic review and meta-analysis

M Marvaldi, J Mallet, C Dubertret, MR Moro… - Neuroscience & …, 2021 - Elsevier
Healthcare workers have been facing the COVID-19 pandemic, with numerous critical
patients and deaths, and high workloads. Quality of care is related to the mental status of …

Interleukin-1 blockade with high-dose anakinra in patients with COVID-19, acute respiratory distress syndrome, and hyperinflammation: a retrospective cohort study

G Cavalli, G De Luca, C Campochiaro… - The Lancet …, 2020 - thelancet.com
Background Mortality of patients with coronavirus disease 2019 (COVID-19), acute
respiratory distress syndrome (ARDS), and systemic inflammation is high. In areas of …

[HTML][HTML] Microvascular COVID-19 lung vessels obstructive thromboinflammatory syndrome (MicroCLOTS): an atypical acute respiratory distress syndrome working …

F Ciceri, L Beretta, AM Scandroglio, S Colombo… - Critical care and …, 2020 - Elsevier
We suggest the use of MicroCLOTS (microvascular COVID-19 lung vessels obstructive
thromboinflammatory syndrome) as a new name for severe pulmonary coronavirus disease …

The impact of COVID-19 and strategies for mitigation and suppression in low-and middle-income countries

PGT Walker, C Whittaker, OJ Watson, M Baguelin… - Science, 2020 - science.org
The ongoing coronavirus disease 2019 (COVID-19) pandemic poses a severe threat to
public health worldwide. We combine data on demography, contact patterns, disease …

Efficacy and safety of tocilizumab in severe COVID-19 patients: a single-centre retrospective cohort study

C Campochiaro, E Della-Torre, G Cavalli… - European journal of …, 2020 - Elsevier
Background Tocilizumab (TCZ), a humanized monoclonal antibody targeting the interleukin-
6 (IL-6) receptor, has been proposed for the treatment of COVID-19 patients; however …

Early predictors of clinical outcomes of COVID-19 outbreak in Milan, Italy

F Ciceri, A Castagna, P Rovere-Querini, F De Cobelli… - Clinical …, 2020 - Elsevier
Background National health-system hospitals of Lombardy faced a heavy burden of
admissions for acute respiratory distress syndromes associated with coronavirus disease …

[HTML][HTML] Characteristics, treatment, outcomes and cause of death of invasively ventilated patients with COVID-19 ARDS in Milan, Italy

A Zangrillo, L Beretta, AM Scandroglio, G Monti… - Critical Care and …, 2020 - Elsevier
Objective: Describe characteristics, daily care and outcomes of patients with coronavirus
disease 2019 (COVID-19) acute respiratory distress syndrome (ARDS). Design: Case series …

[PDF][PDF] Rehabilitative of COVID-19 patients with acute lower extremity Ischemia and amputation

L Brugliera, A Spina, P Castellazzi… - Journal of …, 2020 - medicaljournalssweden.se
Objective: To evaluate the clinical characteristics and rehabilitation management of patients
who undergo amputation for COVID-19-associated coagulopathy. Methods: Clinical and …

Interleukin-6 blockade with sarilumab in severe COVID-19 pneumonia with systemic hyperinflammation: an open-label cohort study

E Della-Torre, C Campochiaro, G Cavalli… - Annals of the rheumatic …, 2020 - Elsevier
Objectives To assess the safety and efficacy of interleukin (IL)− 6 blockade with sarilumab in
patients with severe COVID-19 pneumonia and systemic hyperinflammation. Methods We …